“Since we have been using the Canon 3T MRI for mpMRI of the prostate we have had excellent results in detecting significant prostate cancers. Our patients like the wide bore and NOT having to use an endorectal coil. Our urologists are very pleased with our results and tell us we are making a substantial impact on the care of their patients, in particular those on active surveillance. Our volume continues to increase. Using MRI-US fusion to guide biopsies has improved detection rates with several patients with negative random biopsies having significant prostate cancers when image guided biopsies were performed.”
—Dr. Richard G. Barr MD, Ph.D., FACR, FSRU, President, Radiology Consultants Inc., Youngstown, Ohio
Dr. Richard G. Barr, MD, Ph.D. is a passionate advocate for the use and dissemination of MRI as one of the main imaging modality in the Prostate Cancer care spectrum. He is the Editor-in-Chief for the Journal of Ultrasound in Medicine. He is also a Professor at Northeastern Ohio Medical University and Youngstown State University.
Dr. Barr has published numerous articles, is an invited reviewer of many high-impact journals and provides various lectures worldwide. Dr. Barr’s research has been highlighted in Newsweek, Time, and Reader’s Digest.
“The use of multi-parametric MRI followed by MRI fusion guided prostate biopsy has significantly improved our practices with early detection of clinically meaningful prostate cancer. Our patients now are able to have earlier access to treatment because of early and accurate detection.”
—Dr. Nicholas R. Styn MD, N.E.O. Urology Associates Inc., Boardman, Ohio
Dr. Nicholas R. Styn, MD is a board-certified urologist with extensive experience on prostate cancer. At his practice, Dr. Styn uses the MRI prostate findings as an important diagnostic tool for individualized patient care and disease management. He is an active member of the American Urological Association and the Endourological Society and was recognized by the International Alpha Omega Alpha Medical Honor Society.
Lesion
Number |
Sector | Size
(mm) |
T2WI
PI-RADS (1-5/X) |
DWIPI-RADS
(1-5/X) |
DCE
(+/-) |
EPE
(Y/N) |
PI-RADSv2
FINAL (1-5) |
---|---|---|---|---|---|---|---|
1 | RT BASE
TZ |
14 | 4 | 4 | - | N | 4 |
Lesion
Number |
Sector | Size
(mm) |
T2WI
PI-RADS (1-5/X) |
DWIPI-RADS
(1-5/X) |
DCE
(+/-) |
EPE
(Y/N) |
PI-RADSv2
FINAL (1-5) |
---|---|---|---|---|---|---|---|
1 | RT TZ and MID | 13 | 4 | 4 | + | N | 4 |
Lesion
Number |
Sector | Size
(mm) |
T2WI
PI-RADS (1-5/X) |
DWIPI-RADS
(1-5/X) |
DCE
(+/-) |
EPE
(Y/N) |
PI-RADSv2
FINAL (1-5) |
---|---|---|---|---|---|---|---|
1 | RT MID
TZ |
6 | 3 | 5 | + | N | 5 |
Lesion
Number |
Sector | Size
(mm) |
T2WI
PI-RADS (1-5/X) |
DWIPI-RADS
(1-5/X) |
DCE
(+/-) |
EPE
(Y/N) |
PI-RADSv2
FINAL (1-5) |
---|---|---|---|---|---|---|---|
1 | RT MID
PZ |
16 | 3 | 5 | + | N | 5 |
Sequence | FOV | Resolution | Scan Time | Other Parameters |
---|---|---|---|---|
Sag T2 | 19x19 | 0.3 x 0.3 | 6:36 | |
Cor T2 | 19x19 | 0.4 x 0.4 | 3:16 | |
Ax T2 | 20x20 | 0.4 x 0.4 | 3:05 | |
Ax Dynamic | 25x18 | 0.7 x 0.7 | 0:07 | 7 sec/phase for 3 minutes |
Ax DWI | 24x32 | 1.3 x 1.3 | 3:17 | IsoDWI, ADC |
REFERENCES
1. American Cancer Society. Cancer Facts & Figures 2018. Atlanta, Ga: American Cancer Society; 2018.
2. PI-RADS Prostate Imaging-Reporting and Data Systems. 2015 Version 2. American College of Radiology.
3. Kim BS, Kim TH, Kwon TG, Yoo ES. Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer. Yonsei Med J 2012; 53(3):550-6.
4. T2- and diffusion-weighted magnetic resonance imaging at 3 T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance. Baur, Alexander D.J. et al. European Journal of Radiology, Volume 85, Issue 6, 1075 - 1084.
Results described in this document are the experience of the author.
Results may vary due to clinical setting, patient presentation, and other factors.
© CANON MEDICAL SYSTEMS CORPORATION
© CANON MEDICAL SYSTEMS CORPORATION
The site you see is the Canon Medical Global website. If you choose region / language, we will link to each regional site.